Solasia Pharma KK
TSE:4597
Solasia Pharma KK
Research & Development
Solasia Pharma KK
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Solasia Pharma KK
TSE:4597
|
Research & Development
-¥403m
|
CAGR 3-Years
41%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Research & Development
-¥2.6B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
PeptiDream Inc
TSE:4587
|
Research & Development
-¥3.2B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Research & Development
-¥8.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-12%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
S
|
StemRIM Inc
TSE:4599
|
Research & Development
-¥1.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
See Also
What is Solasia Pharma KK's Research & Development?
Research & Development
-403m
JPY
Based on the financial report for Dec 31, 2023, Solasia Pharma KK's Research & Development amounts to -403m JPY.
What is Solasia Pharma KK's Research & Development growth rate?
Research & Development CAGR 5Y
23%
Over the last year, the Research & Development growth was 54%. The average annual Research & Development growth rates for Solasia Pharma KK have been 41% over the past three years , 23% over the past five years .